Fintel reports that on October 31, 2025, Stifel maintained coverage of DXC Technology (NYSE:DXC) with a Hold recommendation.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Dxc Technology Company ( ($DXC) ) has released its Q2 earnings. Here is a breakdown of the information Dxc Technology Company presented to its ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

This is read by an automated voice. Please report any issues or inconsistencies here. The new acting director of the U.S. Centers for Disease Control and Prevention has announced changes to the ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Chelsea Cirruzzo is a Washington correspondent at STAT, where she ...

Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...

It's fall, y'all, and you know what that means—temperatures and leaves drop, football season is in full swing, pumpkin spice everything takes over your senses...and COVID-19 is likely to run rampant ...

Just in time for respiratory virus season, a highly transmissible COVID-19 strain is fueling a wave of infections across the US. The XFG variant, informally known as “Stratus,” has been driving up ...